These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22974322)

  • 1. Clinicopathological risk factors of Stage II colon cancer: results of a prospective study.
    Santos C; López-Doriga A; Navarro M; Mateo J; Biondo S; Martínez Villacampa M; Soler G; Sanjuan X; Paules MJ; Laquente B; Guinó E; Kreisler E; Frago R; Germà JR; Moreno V; Salazar R
    Colorectal Dis; 2013 Apr; 15(4):414-22. PubMed ID: 22974322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
    Cienfuegos JA; Martínez P; Baixauli J; Beorlegui C; Rosenstone S; Sola JJ; Rodríguez J; Hernández-Lizoáin JL
    Ann Surg Oncol; 2017 Apr; 24(4):1077-1084. PubMed ID: 27624582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
    Skancke M; Arnott SM; Amdur RL; Siegel RS; Obias VJ; Umapathi BA
    Dis Colon Rectum; 2019 Feb; 62(2):181-188. PubMed ID: 30640833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer.
    Fujita S; Nakanisi Y; Taniguchi H; Yamamoto S; Akasu T; Moriya Y; Shimoda T
    Dis Colon Rectum; 2007 Nov; 50(11):1860-6. PubMed ID: 17899273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
    Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of perineural invasion and/or lymphovascular invasion on the survival of early-stage oral squamous cell carcinoma patients.
    Chen TC; Wang CP; Ko JY; Yang TL; Hsu CW; Yeh KA; Chang YL; Lou PJ
    Ann Surg Oncol; 2013 Jul; 20(7):2388-95. PubMed ID: 23361897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of perineural invasion in early-stage cervical cancer.
    Elsahwi KS; Barber E; Illuzzi J; Buza N; Ratner E; Silasi DA; Santin AD; Azodi M; Schwartz PE; Rutherford TJ
    Gynecol Oncol; 2011 Dec; 123(3):561-4. PubMed ID: 21968340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
    Huh JW; Kim HR; Kim YJ
    Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected non-small cell lung cancer.
    Yilmaz A; Duyar SS; Cakir E; Aydin E; Demirag F; Karakaya J; Yazici U; Erdogan Y
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):664-70. PubMed ID: 21334917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.
    Kim DH; Kim SM; Hyun JK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Ann Surg Oncol; 2013 Jul; 20(7):2317-27. PubMed ID: 23677605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy.
    Gertler R; Rosenberg R; Schuster T; Friess H
    Eur J Cancer; 2009 Nov; 45(17):2992-9. PubMed ID: 19682890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Stratification in Patients with Stage II Colon Cancer.
    Amri R; England J; Bordeianou LG; Berger DL
    Ann Surg Oncol; 2016 Nov; 23(12):3907-3914. PubMed ID: 27380640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, Patterns, and Predictors of Locoregional Recurrence in Colon Cancer.
    Liska D; Stocchi L; Karagkounis G; Elagili F; Dietz DW; Kalady MF; Kessler H; Remzi FH; Church J
    Ann Surg Oncol; 2017 Apr; 24(4):1093-1099. PubMed ID: 27812826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
    O'Connell MJ; Campbell ME; Goldberg RM; Grothey A; Seitz JF; Benedetti JK; André T; Haller DG; Sargent DJ
    J Clin Oncol; 2008 May; 26(14):2336-41. PubMed ID: 18467725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.
    Gray RG; Quirke P; Handley K; Lopatin M; Magill L; Baehner FL; Beaumont C; Clark-Langone KM; Yoshizawa CN; Lee M; Watson D; Shak S; Kerr DJ
    J Clin Oncol; 2011 Dec; 29(35):4611-9. PubMed ID: 22067390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative intra-abdominal infection is an independent prognostic factor of disease-free survival and disease-specific survival in patients with stage II colon cancer.
    Sánchez-Velázquez P; Pera M; Jiménez-Toscano M; Mayol X; Rogés X; Lorente L; Iglesias M; Gallén M
    Clin Transl Oncol; 2018 Oct; 20(10):1321-1328. PubMed ID: 29623587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.